Cynthia Schwalm Insider Trading
Get free email notifications about insider trading for Cynthia Schwalm.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cynthia Schwalm. Cynthia Schwalm is a Director in CALADRIUS BIOSCIENCES, INC. ($NBS) and a in Kadmon Holdings, Inc. ($KDMN) and a in G1 Therapeutics, Inc. ($GTHX) and a Director in G1 Therapeutics, Inc. ($GTHX).
Address: C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR. 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK 27709 NC
Companies in which Cynthia Schwalm is an Insider
CALADRIUS BIOSCIENCES, INC.
Trading Symbol: NBSIndustry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Cynthia Schwalm: Director
Holdings: 80,417 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
G1 Therapeutics, Inc.
Trading Symbol: GTHXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cynthia Schwalm: Director
Holdings: 1,500 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kadmon Holdings, Inc.
Trading Symbol: KDMNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cynthia Schwalm:
Holdings: 9,307 shares
Current Value: $37,135
Latest Transaction: May 13 2021
$KDMN Market Capitalization: $176.71M
$KDMN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Cynthia Schwalm
Sentiment: All, NBS, GTHX, KDMN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 3.58 | 96,975 | 347,171 | 96,975 | ||
Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 0.00 | 37,735 | 0 | 80,417 | 42.7 K to 80.4 K (+88.41 %) |
Jun 12 2020 | GTHX | G1 Therapeutics, I ... | Schwalm Cynthia | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
May 14 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Option Exercise | A | 4.44 | 85,034 | 377,551 | 85,034 | ||
Mar 12 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Buy | P | 3.24 | 21,693 | 70,285 | 31,000 | 9.3 K to 31 K (+233.08 %) | |
Mar 12 2020 | KDMN | Kadmon Holdings, I ... | Schwalm Cynthia | Buy | P | 3.24 | 9,307 | 30,108 | 9,307 | 0 to 9.3 K | |
Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | Schwalm Cynthia | Director | Grant | A | 3.28 | 18,292 | 59,998 | 42,682 | 24.4 K to 42.7 K (+75.00 %) |